Obermatt
See Similar Stocks →

Tyra Biosciences

NSQ:TYRA · US90240B1061
BiotechnologySmall

360° View

no current rank
Price/Sales—
Price/Earnings79
Price/Book31
Dividend Yield—
Revenue Growth—
Profit Growth45
Capital Growth88
TSR 52w82
Leverage84
Liquidity25
Refinancing73
Combined—
Analyst Opinions51
Pro Holdings69
Opinion Changes74
Market Pulse81

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded2018
Employees80
Websitetyra.bio
ISINUS90240B1061
Last UpdateApr 2, 2026
Index & Theme
GeneticsUrologyHepatologyGenetic DisorderOncologyBiotechnologyLife ScienceTherapeutics

Description

Tyra Biosciences, Inc. is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, with an initial focus on Fibroblast Growth Fac…

Similar Stocks

The companies this stock is ranked against.

Compare Tyra Biosciences with its peers
Prelude Therapeutics
NSQ:PRLD
49
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Tango Therapeutics
NMQ:TNGX
16
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Black Diamond Therapeutics
NSQ:BDTX
21
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
ArriVent BioPharma
NMQ:AVBP
89
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Nuvectis Pharma
NAQ:NVCT
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Quince Therapeutics
NSQ:QNCX
4
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →